Dr. Osorio is a innovative businessman with an distinct entrepreneurial mindset concentrated in adding value on the areas of Biotechnology (mRNA), Reprogramming & Regenerative Medicine for translational use in humans and a variety of clinical applications aimed for both the private and the public health sectors. He is the CEO of RegenerAge Clinic and RegenerAge Beauty. VP and Clinical Developer for Bioquark, Inc., CCO at Reanima Advance Biosciences Project. President at Dr. Jois an anti-aging, beauty, and cosmetic products endorsement company. VP and Chairman of the WAMS Americas Division. Earned MD degree at Westhill University. Diplomate in aesthetic medicine (UAG), Advance Fellow by the ABAARM, visiting scholar at UNC at Chapel Hill in Dermatology. Fellow in Stem Cell Medicine by the A4M and USF, Business Diplomate at ECA, enrolled Master on Health Sciences at Victoria University. Has appeared on several occasions on International media, some of his latest broadcast appearances are CNN español, TV Azteca, Excelsior Newspaper, Medicable, PharmaBoard Room, and Podcasts among others. His public appearances as a speaker at the 2018 RAADfest (San Diego), 3rd International Conference on Molecular Medicine and Diagnostics (Dubai), Global Academic Business Forum on Tissue Engineering and Regenerative Medicine (Baltimore), Second International Congress on mHealth (Shiraz), 6th International Conference on Tissue Engineering and Regenerative Medicine (S.F), 11th World Congress on Cell & Tissue Science (Tokyo), 17th International Conference on Neurology and Neuroscience (Toronto), 9th International Conference & Exhibition on Tissue Science and Regenerative Medicine (Las Vegas) among others, makes him a pioneer on the Regenerative+Reprogramming Medicine Field. His passion for football, brought as a result the Dr.Jois Foundation A.C aimed at helping those American football athletes who have sustained injury get another chance through the Regenerative & Reprogramming Medicine.
Zeliha Selamoglu is a Professor in Medical Biology department of Ömer Halisdemir University, Turkey. She completed her PhD in Biology from Inonu University. She has published over 70 peer reviewed journal articles with over 500 citations and many technical reports. She is a member of Society for Experimental Biology and Medicine. She has served as an Editorial Board Member for many Journals.
Medical Biology, Molecular Biology, Biochemistry, Biotechnology, Oxidative stress, Antioxidants, Cancer
Dr. Ian James Martins is an Editor/Reveiwer for Open Acess Pub/MDPI journals and various other international journals. Advisory Board Member for Photon Journal. Fellow of International Agency for Standards and Ratings (IASR). Conferred with the RICHARD KUHN RESEARCH AWARD-2015 ENDOCRINOLOGY AND METABOLISM. Chief Editor for International Journal of Diabetes Research (2014-2018), Research and Reviews: Neuroscience (2016-2018) and Journal of Diabetes and Clinical Studies (2017-2018). BIT Member (BIT Congress. Inc) with an H-index of 64, (ResearchGate STATs (27), Scopus Author ID: 7103152779/Mendeley STATS (21), UWA Research Repository (16). Scientist for The Science Advisory Board (USA) and an Academic with Academia.edu. The citations past 27 years have accumulated to >4584. Ian James Martins - Semantic Scholar https://www.semanticscholar.org/author/Ian-James-Martins/5258067. Semantic Scholar profile for Ian James Martins, with fewer than 50 highly influential citations
Prof. H.P.Puttaraju obtained B.Sc. and M.Sc. degree in Zoology from University of Mysore and started his research career in Bangalore University with the DST project fellowship on Mosquito cytogenetics and obtained Ph.D degree.Carried out research and teaching at Master‘s level for over 30 years. He is the Professor of Sericulture/life sciences and founder Coordinator & Chairman (BOS/BOE)for Biological Sciences and founder Coordinator for UGC-Innovative Programme ,School of Natural Science of Bangalore University, at present.Received prestigious Commonwealth Academic staff fellowship to carryout research for one year (1998-1999) at Cardiff University of Wales, UK. Selected as visiting scientist, University of Bremen, Germany under DFG-INSA bilateral exchange programmes 2010.Received funding for personal research and coordinated projects from UGC, DST, DBT,DST,ICMR, DAE-BRNS and from Bangalore University.Prof. H.P.Puttaraju obtained B.Sc. and M.Sc. degree in Zoology from University of Mysore and started his research career in Bangalore University with the DST project fellowship on Mosquito cytogenetics and obtained Ph.D degree. Published over150 research papers, articles in national and international journals of high repute, 3 books and guided successfully 17Ph.Ds and 7 M.Phil research degrees.Published over150 research papers, articles in national and international journals of high repute, 3 books and guided successfully 17Ph.Ds and 7 M.Phil research degrees.
Dr. Sergey Suchkov, MD, Ph.D. Professor in Immunology & Medicine. Personal: Born 11 January 1957, Astrakhan, Russia.Honors: Secretary-General, United Cultural Convention, Cambridge, UK. Memberships: New York Academy of Sciences, USA; European Association for Predictive, Preventive and Personalized Medicine, Brussels; American Association for Research in Vision and Ophthalmology; International Society for Eye Research; EPMA Journal, Personalized Medicine Universe, Open J.Autoimmunity and American J.Cardiovascular Res. Editorial Boards; All-Union (from 1992 - Russian) Biochemical Society; All-Union (from 1992 - Russian) Immunological Society.
Segundo Mesa Castillo is a Specialist in Neurology; he has worked for 10 years in the Institute of Neurology of Havana, Cuba. He has worked with Electron Microscopy on Schizophrenia for 32 years. He was awarded with the International Price of the Stanley Foundation Award Program and for the Professional Committee to work as a fellowship position in the Laboratory of the Central Nervous System Studies, National Institute of Neurological Diseases and Stroke under Dr. Joseph Gibbs for a period of 6 months, National Institute of Health, Bethesda, Washington DC USA.
Genome editing therapeutic projects